Imidapril: Difference between revisions
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
<div style="float: right;"> | <div style="float: right;"> | ||
[[File:Imidapril.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div> | [[File:Imidapril.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div> | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
'''Imidapril''' ([[International Nonproprietary Name|INN]]) is an [[ACE inhibitor]] used as an [[antihypertensive]] drug and for the treatment of [[chronic heart failure]]. | '''Imidapril''' ([[International Nonproprietary Name|INN]]) is an [[ACE inhibitor]] used as an [[antihypertensive]] drug and for the treatment of [[chronic heart failure]]. | ||
==References== | ==References== | ||
| Line 17: | Line 13: | ||
[[Category:ACE inhibitors]] | [[Category:ACE inhibitors]] | ||
[[Category:Amides]] | [[Category:Amides]] | ||
[[Category:Carboxylic acids]] | [[Category:Carboxylic acids]] | ||
[[Category:Drug]] | [[Category:Drug]] | ||
Latest revision as of 17:18, 7 April 2015
|
WikiDoc Resources for Imidapril |
|
Articles |
|---|
|
Most recent articles on Imidapril |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Imidapril at Clinical Trials.gov Clinical Trials on Imidapril at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Imidapril
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Imidapril Discussion groups on Imidapril Directions to Hospitals Treating Imidapril Risk calculators and risk factors for Imidapril
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Imidapril |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Imidapril (INN) is an ACE inhibitor used as an antihypertensive drug and for the treatment of chronic heart failure.